El Hospital Nacional Alberto Sabogal Sologuren, antes llamado Policlínico Obrero del Callao, es un centro hospitalario público peruano, situado en el Callao y administrado por EsSalud.

During the past decade, Hospital Alberto Sabogal Sologuren conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 6 clinical trials were completed, i.e. on average, 85.7% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 4 clinical trials were completed. i.e. 133.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Alberto Sabogal Sologuren" #1 sponsor was "Pfizer" with 2 trials, followed by "Universidad Peruana Cayetano Heredia" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Columbia University" with 1 trials sponsored and "Corvus Pharmaceuticals, Inc." with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Alberto Sabogal Sologuren" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Hospital Nacional Alberto Sabogal Sologuren" with 1 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator and "University of Minnesota" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Alberto Sabogal Sologuren" are "Arthritis, Rheumatoid" (2 trials), "Amyotrophic Lateral Sclerosis" (1 trials), "Anxiety" (1 trials), "Breast Neoplasms" (1 trials) and "Caloric Deficit" (1 trials). Many other conditions were trialed in "Hospital Alberto Sabogal Sologuren" in a lesser frequency.

Most popular intervention types in "Hospital Alberto Sabogal Sologuren" are "Drug" (9 trials), "Other" (2 trials), "Behavioral" (1 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "CP-690,550" (2 trials), "Acthar" (1 trials), "Acthar Gel" (1 trials) and "Baloxavir Marboxil" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Alberto Sabogal Sologuren" are 12 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Alberto Sabogal Sologuren". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 8 completed trials in Hospital Alberto Sabogal Sologuren, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Alberto Sabogal Sologuren, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 1 trials that are defined as “Not Applicable".